This essay was published by STAT on November 4, 2021.
By Dr. Carrie Teicher
At the same time, only 3.9% of people in low-income countries have received even a single dose of Covid-19 vaccine.announced its intent to purchase 110 million doses of the company’s Covid-19 vaccine, most low-income countries have yet to secure any doses and the company refuses to share information that would allow other manufacturers to produce its mRNA vaccine and help end this global pandemic.
The federal government gave Moderna $10 billion in taxpayer money for research and development and for advanced purchases of the vaccine. This includes almost the entire cost of clinical development and the purchase of 500 million doses. Moderna also used patent and nonexclusive rights that the government made available to the company to make this Covid-19 vaccine.
After receiving so much public funding from U.S. taxpayers, Moderna has not lived up to its stated commitment to use its “resources to bring this pandemic to an end as quickly as possible.”
Given the tremendous support it received from the U.S. government and taxpayers, the company has a responsibility to help vaccinate the world to save lives and stem the development of new variants that may prolong the pandemic indefinitely.
Click here to read the complete essay on STAT.